ADPT

Adaptive Biotechnologies Stock Analysis

AI Rating

Neutral
  • Quality2/10
  • Growth↑ 8/10
  • Value↓ 1/10
Adaptive Biotechnologies sales and earnings growth
ADPT Growth
Good
  • Revenue Y/Y↑ 50.40%
  • EPS Y/Y↑ 65.26%
  • FCF Y/Y↑ 66.72%
Adaptive Biotechnologies gross and profit margin trends
ADPT Profitability
Neutral
  • Gross margin ↑ 75.30%
  • EPS margin↓ -16.80%
  • ROIC 5Y↓ -24.43%
Adaptive Biotechnologies net debt vs free cash flow
ADPT Risk
Great
  • Debt / Equity↓ 0.9
  • Debt / FCF↓ 4.3
  • Interest coverage↓ -3.2

Adaptive Biotechnologies stock volatility is in-line with the overall market. We give it a Great risk rating.

↗ More Biotechnology stocks